Galectin Therapeutics Inc. (GALT) Earnings
NASDAQ·Healthcare·Biotechnology
$3.50
+3.24%
Mkt Cap $228.52M
EPS — Estimate vs Actual
Mkt Cap
$228.52M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.48
NASDAQ·Healthcare·Biotechnology
$3.50
+3.24%
Mkt Cap $228.52M
Mkt Cap
$228.52M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.48